AI Blogs and Articles
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

AI Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
AIBlogs🧑‍🚀 Palantir Profits, AI Therapy Crackdown, & Bubble Fears
🧑‍🚀 Palantir Profits, AI Therapy Crackdown, & Bubble Fears
AI

🧑‍🚀 Palantir Profits, AI Therapy Crackdown, & Bubble Fears

•November 28, 2025
0
Matthew Berman
Matthew Berman•Nov 28, 2025

Why It Matters

These developments tighten regulatory scrutiny, shift AI supply chains, and spur strategic consolidation, reshaping market dynamics and investor risk assessments.

Key Takeaways

  • •Palantir revenue up 63%, profit up 248% YoY
  • •FDA holds first AI‑therapy chatbot hearing
  • •OpenAI exposed user names via Mixpanel breach
  • •Chinese firms train AI overseas to bypass chip export bans
  • •Bezos’ Prometheus acquires General Agents, raising $6B fund

Pulse Analysis

The AI sector continues to attract both hype and hard data, and recent earnings from Palantir illustrate how a company can convert buzz into measurable profit. In the July‑September quarter the data‑analytics firm reported a 63 percent year‑on‑year revenue increase and a 248 percent jump in operating profit, pushing its operating margin into positive territory. Analysts note that such growth challenges the narrative of an over‑inflated AI bubble, suggesting that firms with deep integration and high‑touch deployment models are beginning to generate sustainable cash flows even as market multiples remain lofty.

Regulators are moving in step with the technology, as the U.S. Food and Drug Administration held its inaugural public hearing on AI‑driven therapy chatbots. Lawmakers and clinicians are weighing the promise of scalable mental‑health support against the risk of untested algorithms delivering harmful advice. At the same time, OpenAI confirmed a Mixpanel breach that exposed user identifiers, underscoring the privacy vulnerabilities inherent in third‑party analytics. Across the Pacific, Chinese giants such as Alibaba and ByteDance are relocating model training to Southeast Asian data centers to evade U.S. export controls on advanced NVIDIA chips, reshaping the global AI supply chain.

Strategic consolidation is another hallmark of the current landscape. Jeff Bezos’ Project Prometheus, a stealth AI venture backed by more than $6 billion, recently acquired General Agents, a startup specializing in agentic‑computing, signaling a push toward autonomous AI assistants. The acquisition adds seasoned talent from DeepMind and Tesla, positioning Prometheus to compete in the emerging market for self‑directing software agents. Coupled with a steady flow of mega‑rounds—49 U.S. AI startups have each raised over $100 million this year—the sector is poised for both heightened competition and increased scrutiny, forcing investors to balance growth potential against regulatory and security risks.

🧑‍🚀 Palantir Profits, AI Therapy Crackdown, & Bubble Fears

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...